Q32 Bio (QTTB) Cash from Financing Activities (2017 - 2026)

Q32 Bio's Cash from Financing Activities history runs 10 years deep, the most recent figure standing at $8.8 million for Q1 2026.

• On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $8.8 million in Q1 2026; TTM through Mar 2026 was $6.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$3.1 million, down 103.28% from the prior year.
• Cash from Financing Activities climbed to $8.8 million in Q1 2026 per QTTB's latest filing, from -$1.6 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $99.3 million in Q1 2024 and bottomed at -$5.5 million in Q2 2024.
• The 5-year median for Cash from Financing Activities is $100000.0 (2022), against an average of $7.3 million.
• Biggest YoY gain for Cash from Financing Activities was 662206.67% in 2024; the steepest drop was 36913.33% in 2024.
• Year by year, Cash from Financing Activities stood at $32000.0 in 2022, then surged by 137.5% to $76000.0 in 2023, then surged by 317.11% to $317000.0 in 2024, then sank by 592.74% to -$1.6 million in 2025, then soared by 663.19% to $8.8 million in 2026.
• Per Business Quant, the three latest QTTB Cash from Financing Activities figures stand at $8.8 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.6 million (Q3 2025).